Tag: Glycoprotein inhibitors

Glycoproteins are complex proteins with attached carbohydrate chains that are crucial for numerous biological processes, from cell-to-cell communication to immune system function. As a result, inhibiting specific glycoproteins is a powerful therapeutic strategy in medicine, leading to several classes of drugs. So, **which drugs are glycoprotein inhibitors**? The answer spans several therapeutic areas, most notably cardiology, oncology, and virology.

In the United States, approximately 80 million adults use aspirin for cardioprotective purposes. This widespread use often leads to questions about its specific mechanism of action, including, 'Is aspirin a glycoprotein inhibitor?' The answer is a subtle yet crucial point in pharmacology, highlighting the difference between aspirin's primary mechanism and the actions of a distinct class of antiplatelet drugs.